ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,63
0,11%
Bitcoin
59 258,14
1,75%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Outlook Therapeutics Inc (OTLK)

  7. Outlook Therapeutics Inc (OTLK) Actualités

OTLK Outlook Therapeutics Inc

8,49
-0,01 (-0,12%)
Après les heures de négociation
Dernière mise à jour : 23:32:08
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Outlook Therapeutics Inc OTLK NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,01 -0,12% 8,49 23:32:08
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
8,60 8,2703 8,605 8,49 8,50
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202415:05GLOBEOutlook Therapeutics® to Present at the Retina World..
29/4/202415:00GLOBEOutlook Therapeutics® to Present at the Ophthalmology..
15/4/202422:15GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
22/3/202412:35GLOBEOutlook Therapeutics® Receives European Union Positive CHMP..
18/3/202422:10GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
12/3/202413:05GLOBEOutlook Therapeutics® Announces Effective Date for 1-for-20..
11/3/202421:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:16EDGAR2Form 8-K - Current report
14/2/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202422:40EDGAR2Form 8-K - Current report
14/2/202414:05GLOBEOutlook Therapeutics® Reports Financial Results for First..
08/2/202413:00EDGAR2Form ARS - Annual Report to Security Holders
08/2/202412:59EDGAR2Form DEF 14A - Other definitive proxy statements
31/1/202422:01EDGAR2Form SC 13D/A - General statement of acquisition of..
31/1/202414:05GLOBEOutlook Therapeutics® Doses First Subject in NORSE EIGHT
29/1/202423:00EDGAR2Form PRE 14A - Other preliminary proxy statements
24/1/202423:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24/1/202412:02EDGAR2Form 8-K - Current report
23/1/202414:00GLOBEOutlook Therapeutics® Receives FDA Agreement Under Special..
22/12/202323:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/12/202322:15EDGAR2Form 8-K - Current report
22/12/202314:05GLOBEOutlook Therapeutics® Reports Financial Results for Fiscal..
19/12/202314:05GLOBEOutlook Therapeutics® Submits Special Protocol Assessment..
18/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
06/12/202323:00EDGAR2Form 8-K - Current report
06/12/202314:05GLOBEOutlook Therapeutics® Announces Strategic Organizational..
04/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
29/11/202322:01EDGAR2Form SC 13D/A - General statement of acquisition of..
28/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
27/11/202314:05GLOBEOutlook Therapeutics® Announces Receipt of Type A Meeting..
21/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14/11/202314:05GLOBEOutlook Therapeutics® Adds Global Commercial Expertise with..
14/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
02/11/202313:12EDGAR2Form 8-K - Current report
02/11/202313:05GLOBEOutlook Therapeutics® Provides Update on Type A Meetings..
01/11/202313:05GLOBEOutlook Therapeutics® to Present at Guggenheim’s 5th Annual..
20/10/202323:00EDGAR2Form 8-K - Current report
05/10/202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202314:05GLOBEOutlook Therapeutics® Requests Type A Meeting With FDA
21/9/202314:05GLOBEOutlook Therapeutics® to Present at the 2023 Cantor..
05/9/202314:05GLOBEOutlook Therapeutics® to Present at the H.C. Wainwright 25th..
30/8/202312:21EDGAR2Form 8-K - Current report
30/8/202312:00GLOBEOutlook Therapeutics® Provides Regulatory Update on FDA..

Dernières Valeurs Consultées

NASDAQ
OTLK
Outlook Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés